Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Correction

Correction to: Daphnane diterpenes inhibit the metastatic potential of B16F10 murine melanoma cells in vitro and in vivo

Authors: Myra O. Villareal, Yuki Sato, Kyoko Matsuyama, Hiroko Isoda

Published in: BMC Cancer | Issue 1/2018

Login to get access

Excerpt

Following publication of the original article [1], the authors reported that affiliation number 2 was incomplete. In this Correction, correct and incorrect affiliations are shown. …
Literature
1.
Metadata
Title
Correction to: Daphnane diterpenes inhibit the metastatic potential of B16F10 murine melanoma cells in vitro and in vivo
Authors
Myra O. Villareal
Yuki Sato
Kyoko Matsuyama
Hiroko Isoda
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4805-8

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue

Research article

Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysis

Research article

Bioelectrical impedance analysis for monitoring cancer patients receiving chemotherapy and home parenteral nutrition

Research article

Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study

Research article

Projected lifetime cancer risks from occupational radiation exposure among diagnostic medical radiation workers in South Korea

Research article

PEST-containing nuclear protein mediates the proliferation, migration, and invasion of human neuroblastoma cells through MAPK and PI3K/AKT/mTOR signaling pathways

Research article

NSCLC molecular testing in Central and Eastern European countries
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits